Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RUTI for mild COVID-19
NCT05115019Phase 3Withdrawn
- Sponsor
- Innovative Pharma Solutions
- Start
- Dec 2021
- Primary completion
- Feb 2022
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
01
Overview
A Phase 3 trial of RUTI vaccine in coronavirus disease 2019 (COVID-19), sponsored by Innovative Pharma Solutions. Planned start Dec 2021; status: withdrawn.
02
Drugs
RUTI vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05115019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05115019.